Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.08% |
| 2 | Financials | 6.03% |
| 3 | Industrials | 5.01% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Healthcare | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANCX
6351
DELISTED
Access National Corp
ANCX
| $291K | ﹤0.01% |
+10,458
| New | +$300K |
|
|
STKL
6352
DELISTED
SunOpta
STKL
| $290K | ﹤0.01% |
37,451
-17,122
| -31% | -$143K |
|
6353
Idacorp
IDA
$8.15B
| $289K | ﹤0.01% |
+3,167
| New | +$296K |
|
6354
Innoviva
INVA
$1.56B
| $289K | ﹤0.01% |
20,395
-140,061
| -87% | -$1.87M |
|
|
VGR
6355
PUT
DELISTED
Vector Group Ltd.
VGR
| $289K | ﹤0.01% |
20,053
-21,771
| -52% | -$303K |
|
|
OSB
6356
DELISTED
Norbord Inc.
OSB
| $289K | ﹤0.01% |
+8,536
| New | +$305K |
|
|
WPG
6357
CALL
DELISTED
Washington Prime Group Inc.
WPG
| $289K | ﹤0.01% |
4,511
+2,311
| +105% | +$157K |
|
6358
CALL
Artisan Partners
APAM
$3.06B
| $288K | ﹤0.01% |
7,300
-500
| -6% | -$18.5K |
|
6359
Descartes Systems
DSGX
$6.67B
| $288K | ﹤0.01% |
+10,145
| New | +$292K |
|
6360
CALL
Globus Medical
GMED
$11B
| $288K | ﹤0.01% |
7,000
-1,300
| -16% | -$45.5K |
|
6361
PUT
Hovnanian Enterprises
HOV
$789M
| $288K | ﹤0.01% |
3,440
-256
| -7% | -$15.8K |
|
6362
PUT
Malibu Boats
MBUU
$562M
| $288K | ﹤0.01% |
+9,700
| New | +$296K |
|
6363
PUT
Star Bulk Carriers
SBLK
$3.19B
| $288K | ﹤0.01% |
25,600
+11,400
| +80% | +$118K |
|
6364
W.P. Carey
WPC
$16.4B
| $288K | ﹤0.01% |
+4,267
| New | +$292K |
|
|
NS
6365
CALL
DELISTED
NuStar Energy L.P.
NS
| $288K | ﹤0.01% |
9,600
+1,600
| +20% | +$51.9K |
|
|
CBM
6366
CALL
DELISTED
Cambrex Corporation
CBM
| $288K | ﹤0.01% |
6,000
-6,600
| -52% | -$327K |
|
6367
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.18M
| $287K | ﹤0.01% |
1,628
+94
| +6% | +$16.7K |
|
|
BBBY
6368
Bed Bath & Beyond
BBBY
$429M
| $287K | ﹤0.01% |
5,982
-14,945
| -71% | -$540K |
|
6369
CALL
Choice Hotels
CHH
$4.99B
| $287K | ﹤0.01% |
+3,700
| New | +$270K |
|
6370
PUT
Celldex Therapeutics
CLDX
$3.26B
| $287K | ﹤0.01% |
6,740
-13
| -0.2% | -$557 |
|
6371
iShares Latin America 40 ETF
ILF
$3.8B
| $287K | ﹤0.01% |
+8,387
| New | +$285K |
|
6372
PUT
Global X Social Media ETF
SOCL
$92.2M
| $287K | ﹤0.01% |
+8,700
| New | +$286K |
|
|
RTEC
6373
PUT
DELISTED
Rudolph Technologies Inc
RTEC
| $287K | ﹤0.01% |
+12,000
| New | +$308K |
|
6374
Select Water Solutions
WTTR
$2.57B
| $286K | ﹤0.01% |
+15,690
| New | +$252K |
|
|
AVTA
6375
DELISTED
Avantax, Inc. Common Stock
AVTA
| $286K | ﹤0.01% |
12,953
+4,595
| +55% | +$102K |
|
Similar funds
Citadel Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Citadel Advisors opened 1,440 new positions and closed 988 in Q4 2017.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.